Logo.jpg
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
November 07, 2022 19:12 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
ProPhase Labs to Present at The ThinkEquity Conference
October 18, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
October 17, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Logo.jpg
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
August 11, 2022 08:00 ET | ProPhase Labs, Inc.
Record Q2 2022 Net Revenues of $29.1 Million; Up 218% Year-over-Year Record Q2 2022 Net Income of $7.4 Million; Up 633% Year-over-Year Management to Host Conference Call Today at 11:00...
Logo.jpg
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
August 04, 2022 20:33 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
Logo.jpg
ProPhase Labs Announces Significant Laboratory Expansion
June 13, 2022 08:30 ET | ProPhase Labs, Inc.
Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a...
Logo.jpg
ProPhase Labs Announces Record First Quarter 2022 Financial Results
May 13, 2022 08:30 ET | ProPhase Labs, Inc.
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per...
Logo.jpg
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
May 10, 2022 08:15 ET | ProPhase Labs, Inc.
Garden City, NY, May 10, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified diagnostics and genomics company, announced today that Bill White has been appointed Chief...